Role of Connective Tissue Growth Factor in Oval Cell Response During Liver Regeneration After 2-AAF/PHx in Rats  Liya Pi, Seh-Hoon Oh, Thomas Shupe, Bryon.

Slides:



Advertisements
Similar presentations
Teratoma Formation Leads to Failure of Treatment for Type I Diabetes Using Embryonic Stem Cell-Derived Insulin-Producing Cells  Takahisa Fujikawa, Seh-Hoon.
Advertisements

Journal of Surgical Research
Reduced Tumor Necrosis Factor-α and Transforming Growth Factor-β1 Expression in the Lungs of Inbred Mice that Fail to Develop Fibroproliferative Lesions.
Volume 138, Issue 2, Pages e3 (February 2010)
Volume 123, Issue 5, Pages (November 2002)
Tranilast attenuates connective tissue growth factor-induced extracellular matrix accumulation in renal cells  W. Qi, X. Chen, S. Twigg, T.S. Polhill,
Volume 68, Issue 6, Pages (December 2005)
Volume 131, Issue 4, Pages (October 2006)
Volume 137, Issue 2, Pages e2 (August 2009)
Development of Cell-Penetrating Asymmetric Interfering RNA Targeting Connective Tissue Growth Factor  Jihye Hwang, Chanil Chang, Ji Hyun Kim, Chang Taek.
Volume 128, Issue 5, Pages (May 2005)
Volume 133, Issue 5, Pages e1 (November 2007)
Volume 56, Issue 4, Pages (October 1999)
Volume 133, Issue 2, Pages (August 2007)
Glial Cell–Derived Neurotrophic Factor Enhances Synaptic Communication and 5- Hydroxytryptamine 3a Receptor Expression in Enteric Neurons  Fanning Zeng,
Growth Hormone Inhibits Signal Transducer and Activator of Transcription 3 Activation and Reduces Disease Activity in Murine Colitis  Xiaonan Han, Danuta.
PTF1α/p48 and cell proliferation
Impaired Wound Repair in Adult Endoglin Heterozygous Mice Associated with Lower NO Bioavailability  Eduardo Pérez-Gómez, Mirjana Jerkic, Marta Prieto,
Smad7 gene transfer inhibits peritoneal fibrosis
Volume 124, Issue 1, Pages (January 2003)
Qixu Zhang, Qing Chang, Robert A. Cox, Xuemei Gong, Lisa J. Gould 
Volume 128, Issue 7, Pages (June 2005)
Volume 129, Issue 1, Pages (July 2005)
IN-1130, a novel transforming growth factor-β type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy  J.-A. Moon,
Volume 60, Issue 2, Pages (August 2001)
Anti-fibrotic Effects of Synthetic Oligodeoxynucleotide for TGF-β1 and Smad in an Animal Model of Liver Cirrhosis  Jung-Yeon Kim, Hyun-Jin An, Woon-Hae.
Volume 140, Issue 1, Pages (January 2011)
Volume 130, Issue 4, Pages (April 2006)
Volume 141, Issue 4, Pages e2 (October 2011)
Volume 114, Issue 3, Pages (March 1998)
Volume 136, Issue 7, Pages (June 2009)
Volume 127, Issue 1, Pages (July 2004)
Volume 69, Issue 2, Pages (August 2018)
Volume 138, Issue 2, Pages e3 (February 2010)
Volume 134, Issue 2, Pages e3 (February 2008)
Volume 135, Issue 2, Pages (August 2008)
Volume 65, Issue 2, Pages (February 2004)
Volume 134, Issue 4, Pages (April 2008)
Volume 73, Issue 4, Pages (February 2008)
Volume 129, Issue 5, Pages (November 2005)
Volume 126, Issue 3, Pages (March 2004)
Sustained Activation of Fibroblast Transforming Growth Factor-β/Smad Signaling in a Murine Model of Scleroderma  Shinsuke Takagawa, Gabriella Lakos, Yasuji.
Volume 129, Issue 5, Pages (November 2005)
GLI2 Is a Regulator of β-Catenin and Is Associated with Loss of E-Cadherin, Cell Invasiveness, and Long-Term Epidermal Regeneration  Eleni Pantazi, Emilios.
Overexpression of CD109 in the Epidermis Differentially Regulates ALK1 Versus ALK5 Signaling and Modulates Extracellular Matrix Synthesis in the Skin 
Volume 57, Issue 3, Pages (March 2000)
Volume 63, Issue 4, Pages (April 2003)
Volume 41, Issue 6, Pages (December 2004)
Volume 59, Issue 3, Pages (March 2001)
Volume 7, Issue 1, Pages (January 2008)
Inducible Nitric Oxide Synthase Up-Regulates Notch-1 in Mouse Cholangiocytes: Implications for Carcinogenesis  Norihisa Ishimura, Steven F. Bronk, Gregory.
Volume 44, Issue 2, Pages (February 2006)
Volume 19, Issue 8, Pages (August 2011)
Volume 62, Issue 5, Pages (November 2002)
Jacqueline M. Saito*, Jacquelyn J. Maher‡  Gastroenterology 
YAP and TAZ Regulate Skin Wound Healing
Volume 129, Issue 5, Pages (November 2005)
Amphiregulin: An early trigger of liver regeneration in mice
Volume 2, Issue 6, Pages (June 2008)
Connective Tissue Growth Factor: Expression in Human Skin In Vivo and Inhibition by Ultraviolet Irradiation  Taihao Quan, Tianyuan He, Sewon Kang, John.
Effectively regenerating livers transiently accumulate proliferative IGF2BP3-positive cells. Effectively regenerating livers transiently accumulate proliferative.
Volume 136, Issue 7, Pages (June 2009)
Volume 131, Issue 5, Pages (November 2006)
miR-29 Inhibits Bleomycin-induced Pulmonary Fibrosis in Mice
Volume 55, Issue 2, Pages (February 1999)
Jens Gaedeke, Nancy A. Noble, Wayne A. Border  Kidney International 
T-PA promotes glomerular plasmin generation and matrix degradation in experimental glomerulonephritis  Masashi Haraguchi, Wayne A. Border, Yufeng Huang,
Volume 21, Issue 2, Pages (February 2013)
Volume 139, Issue 3, Pages (September 2010)
Volume 56, Issue 4, Pages (October 1999)
Presentation transcript:

Role of Connective Tissue Growth Factor in Oval Cell Response During Liver Regeneration After 2-AAF/PHx in Rats  Liya Pi, Seh-Hoon Oh, Thomas Shupe, Bryon E. Petersen  Gastroenterology  Volume 128, Issue 7, Pages 2077-2088 (June 2005) DOI: 10.1053/j.gastro.2005.03.081 Copyright © 2005 American Gastroenterological Association Terms and Conditions

Figure 1 Massive proliferation of Thy-1+ oval cells in portal region during liver regeneration after 2-AAF/PHx. Frozen liver sections were examined by immunohistochemistry for Thy-1 antigen. Blue color indicates DAPI stained DNA, whereas red indicates Texas red signal for Thy-1 antigen. (A) Normal. (B) 2-AAF/PHx treated liver (day 9). Both images were taken at 200×. Scale bar: 10 μm. Gastroenterology 2005 128, 2077-2088DOI: (10.1053/j.gastro.2005.03.081) Copyright © 2005 American Gastroenterological Association Terms and Conditions

Figure 2 Induction of CTGF expression in the 2-AAF/PHx model. (A) Northern blot analysis of whole liver homogenate shows induction of CTGF message beginning at day 5 and reaching a shoulder peak around day 7 to 9 post PHx. N represents normal liver. (B) Western blot analysis of whole liver homogenate shows accumulation of CTGF protein. Actin was used as a loading control. Gastroenterology 2005 128, 2077-2088DOI: (10.1053/j.gastro.2005.03.081) Copyright © 2005 American Gastroenterological Association Terms and Conditions

Figure 3 Thy-1+ oval cells express CTGF transcript. (A) Real-time PCR shows induction of CTGF in both whole rat liver and Thy-1 sorted oval cells after 2-AAF/PHx compared with those of normal livers. N indicates normal livers. Values in normal livers are arbitrarily assigned to 1 unit. Data represent the mean value ± SD (n ≥ 3). *P < .05. (B) In situ hybridization negative control probed with sense CTGF (200×). Thy-1+ oval cells obtained at day 9 after 2-AAF/PHx treatment shown in (C) and (E) were stained in red. In situ hybridization of the same section with CTGF antisense probe in (D) and (F) shows dark brown signals for CTGF transcripts. Blue arrows indicate the colocalization of CTGF transcripts in Thy-1+ oval cells. Images of B, C, and D were taken at 200×. E and F were taken at 400×. E and F were the large magnifications of C and D, respectively. Gastroenterology 2005 128, 2077-2088DOI: (10.1053/j.gastro.2005.03.081) Copyright © 2005 American Gastroenterological Association Terms and Conditions

Figure 4 Coordinated expression of TGF-β1, pro-collagen type I, and fibronectin in oval cell–aided liver regeneration. Northern blot analysis shows TGF-β1 and ECM proteins are induced simultaneously with CTGF after 2-AAF/PHx treatment in rats. GADPH was used as a loading control. Gastroenterology 2005 128, 2077-2088DOI: (10.1053/j.gastro.2005.03.081) Copyright © 2005 American Gastroenterological Association Terms and Conditions

Figure 5 Iloprost blocks up-regulation of CTGF but does not affect TGF-β1 induction after 2-AAF/PHx treatment. Northern blot analysis showed that CTGF up-regulation is blocked, whereas TGF-β1 expression remains unaffected by Iloprost in 2-AAF/PHx-treated rats. GADPH was used as a loading control. Gastroenterology 2005 128, 2077-2088DOI: (10.1053/j.gastro.2005.03.081) Copyright © 2005 American Gastroenterological Association Terms and Conditions

Figure 6 Decrease in the number of histologically evident oval cells in Iloprost-treated rat liver after 2-AAF/PHx. (A) Portal regions of H&E-stained liver sections from 2-AAF/PHx-treated rats contain an abundance of cells with high nuclear to cytoplasm ratio (40×). (B) Far fewer of these cells are seen in sections from rats that received Iloprost (40×). (C) Magnification of the area outlined in A (400×). (D) Magnification of the area outlined in B (400×). Gastroenterology 2005 128, 2077-2088DOI: (10.1053/j.gastro.2005.03.081) Copyright © 2005 American Gastroenterological Association Terms and Conditions

Figure 7 Decrease in the number of proliferating cells in Iloprost-treated rat livers after 2-AAF/PHx. (A) Portal regions of BrdU-stained liver sections from day 7; 2-AAF/PHx-treated rats contain a high number of proliferating cells (40×). (B) A dramatic decrease in proliferation is seen in sections from rats that received Iloprost (40×). (C) Magnification of the area outlined in A (400×). (D) Magnification of the area outlined in B (400×). (E) Quantitation of BrdU-positive cells in periportal regions at day 5, 7, and 9 after 2-AAF/PHx in Iloprost-treated (black bars) as compared with control (open bars) rats. The number of BrdU-positive cells was counted in >10 periportal areas selected randomly in each specimen stained with hematoxylin. Each value represents the mean ± SD. Gastroenterology 2005 128, 2077-2088DOI: (10.1053/j.gastro.2005.03.081) Copyright © 2005 American Gastroenterological Association Terms and Conditions

Figure 8 AFP message is decreased in Iloprost-treated rat liver after 2-AAF/PHx. (A) Quantitative, real-time PCR shows a substantial reduction in liver AFP message after 2-AAF/PHx treatment in rats that received Iloprost (second set of bars) as compared with control rats (first set of bars). Data are normalized to the Iloprost-treated sample at day 5 after 2-AAF/PHx. Data represent the mean value ± SD (n ≥ 3). (B) AFP expressions at day 5, 7, and 9 in Iloprost-treated animals were significantly reduced compared with those of control animals in a Northern analysis. Gastroenterology 2005 128, 2077-2088DOI: (10.1053/j.gastro.2005.03.081) Copyright © 2005 American Gastroenterological Association Terms and Conditions